Older Veterans EmpoweRed To Use Regular Exercise (OVERTURE) II (OVERTURE)

May 18, 2022 updated by: Karlene K Ball, University of Alabama at Birmingham
The purpose of this study is to investigate the practicality of a short-term (8-weeks), home-based digital versatile disc (DVD) chair exercise program among 40 sedentary older Black/African American and White/Caucasian veterans with three or more chronic health conditions, such as type 2 diabetes, hypertension, and osteoarthritis.

Study Overview

Detailed Description

This study will determine the feasibility of a home-based DVD chair exercise program, "Sit and Be Fit." Participants will be asked to complete a chair-exercise program Monday through Friday. Each chair exercise session lasts approximately 30 minutes. Participants will receive a new DVD player, the exercise DVD, and the necessary exercise equipment to complete each session. The equipment includes a set of 1 pound hand weights, a 10" exercise ball, a small handball, a resistance band, an exercise log, and a satisfaction survey. Upon initial enrollment, both groups will receive a baseline health assessment that will include health-related quality of life, subjective well-being, body mass index (BMI), comorbidity, blood pressure, lower body extremity fitness, physical activity, and hand grip strength. Excluding health status, all other measures will be completed at post-assessment (the end of week 8 for Group A and Group B). The intervention group (Group A) will receive the equipment after completing eligibility screening, an informed consent, and health assessments. The waitlist control group (Group B) will receive the equipment at week 9 after the post-assessment. Group B will complete the program through week 16. The waitlist control group(Group B) will not receive an additional post assessment at the end of week 16.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 99 years (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be a veteran, which will be verified through documentation, such as discharge papers, military identification card, or military photographs
  • Identify as Black/African American or White/Caucasian; demonstrate proof of age 65+; self-report of three or more chronic health conditions
  • Pass a cognitive screening related to thinking/reasoning/decision making; report less than 30 minutes of daily physical activity
  • Systolic blood pressure lower than 180
  • Diastolic blood pressure lower than 100
  • Resting heart rate 90 or lower
  • Three or more chronic health conditions
  • Permission from primary care physician (PCP)
  • Own a sturdy stand-alone chair without arms
  • Own an operable television
  • Willing to be randomized to the intervention or the waitlist control group

Exclusion Criteria:

  • Non-veteran
  • Non-Black or African American/White or Caucasian
  • Younger than 65 years of age
  • Systolic blood pressure 180 or higher
  • Diastolic blood pressure is 100 or higher
  • Resting heart rate higher than 90
  • Less than three chronic health conditions
  • Failure to pass a cognitive screening
  • Report more than 30 minutes of daily physical activity
  • No approval from PCP
  • No sturdy stand-alone chair without arms
  • No operable television
  • Unwilling to be assigned to the intervention or the waitlist control group

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention Group
Ten participants from each racial group (Black/White) will be assigned to the Intervention, which will receive the home-based DVD Chair Exercise Program. This is the group that will receive the chair exercise intervention upon enrollment.
Intervention group participants will receive the home-based DVD chair exercise program, which will include a DVD player, "Sit and Be Fit" DVD, schedule of exercise sessions, hand weights, exercise balls, resistance bands, exercise log, and satisfaction survey. Participants will be instructed to complete an assigned "Sit and Be Fit" exercise session once a day (sessions last approximately 30 minutes), five days a week (Monday-Friday) for 8 weeks. During the first 6 weeks, the intervention group will not have contact with the study team, unless to trouble-shoot the DVD or answer questions about exercise sessions. At the end of week 6, the intervention group will be contacted to schedule a post-assessment for the end of week 8, which will include repeating all health measures, except for health status.
ACTIVE_COMPARATOR: Waitlist Control Group
Ten participants from each racial group (Black/White) will be assigned to the Waitlist Control Group, which will receive the home-based DVD Chair Exercise Program at the end of 8 weeks.
At week 8, waitlist control group will receive the home-based DVD chair exercise program, which will include a DVD player, "Sit and Be Fit" DVD, schedule of exercise sessions, hand weights, exercise balls, resistance bands, exercise log, and satisfaction survey. The waitlist control group will complete a post-assessment at the end of week 8, which will include all health status measures, except health status. Waitlist control group will be instructed to complete an assigned "Sit and Be Fit" exercise session once a day (sessions last approximately 30 minutes), five days a week (Monday-Friday) for 8 weeks. Waitlist control group will not have contact with the study team, unless to trouble-shoot the DVD or answer questions about exercise sessions. At the end 14 weeks, waitlist control group will be contacted to schedule a final meeting, and to collect the adherence logs and satisfaction survey. At 16 weeks, the waitlist control group will not receive an additional post-assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of fitness sessions completed based on participants' activity logs - Adherence to the home-based DVD chair exercise program
Time Frame: At the end of 8 weeks.
Adherence (number of fitness sessions completed based on participants' activity logs). Participants' activity logs will be used to assess subjective completion of fitness sessions.
At the end of 8 weeks.
Number of participants lost to attrition
Time Frame: At the end of 8 weeks.
The number of participants lost to attrition (dropped out). This will be measured by the number of participants that have completed the entire 8 week program. Before and after each session, participants will be instructed to record the date and time the session was started and completed.
At the end of 8 weeks.
Participants' program satisfaction
Time Frame: At the end of 8 weeks.
Satisfaction ratings will be assessed based on participants' satisfaction logs.
At the end of 8 weeks.
Participants' rating of the program
Time Frame: Week 10
Intervention group participants' ratings of the intervention based on open-ended questions asked during the focus group session.
Week 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate the Quality of Life (QOL) of participants
Time Frame: Baseline and post-assessment at week 8.
The 36-Item Short Form Survey (SF-36) will be used to assess QOL outcomes. A 0 score indicates the lowest level of QOL measured by the scale and a 100 indicates the highest level of QOL measured by the scale.
Baseline and post-assessment at week 8.
Subjective Well-being (SWB)
Time Frame: Baseline and post-assessment at week 8.
How an individual rates general feelings of happiness (well-being). SWB will be measured using a modified SWB scale. The scale consists of 4 items that assess overall happiness. Respondents were asked two questions about their happiness as well as two questions comparing their happiness to the happiness of others on a scale from 1 to 7, with 7 reflecting a high degree of perceived happiness. Composite scores on the scale range from 4 to 28.
Baseline and post-assessment at week 8.
Physical Activity
Time Frame: Baseline and post-assessment at week 8.
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity. Score ranges from 0 to 360. A high score indicates a high level of physical activity.
Baseline and post-assessment at week 8.
Blood pressure
Time Frame: Baseline and post-assessment at week 8
Blood pressure (systolic and diastolic) will be assessed using a standard blood pressure cuff.
Baseline and post-assessment at week 8
Heart Rate (Pulse)
Time Frame: Baseline and post-assessment at week 8
Pulse rate will be assessed using a standard blood pressure cuff.
Baseline and post-assessment at week 8
Body Mass Index (BMI)
Time Frame: Baseline and post-assessment at week 8.
BMI will be assessed using a standard weight scale and a folding yardstick.
Baseline and post-assessment at week 8.
Hand Grip Strength
Time Frame: Baseline and post-assessment at week 8.
Hand grip strength will be assessed using a Baseline Hydraulic Hand Dynamometer.
Baseline and post-assessment at week 8.
Short Physical Performance Battery (SPPB)
Time Frame: Baseline and post-assessment at week 8.
The SPPB will assess lower body function with a balance test, gait (walk) test, and chair stands.
Baseline and post-assessment at week 8.
Comorbidity
Time Frame: Baseline
Comorbidity will be assessed using the Charlson Comorbidity Index. Comorbidity is the presence of additional chronic health conditions that can impact life expectancy. Individual chronic conditions will be assigned a score based on severity and averaged. Based on the chronic condition, assigned scores can be 1, 2, 3, or 6.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karlene K Ball, PhD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 24, 2018

Primary Completion (ACTUAL)

July 31, 2020

Study Completion (ACTUAL)

January 31, 2022

Study Registration Dates

First Submitted

June 12, 2018

First Submitted That Met QC Criteria

July 6, 2018

First Posted (ACTUAL)

July 9, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 20, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-300001897

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe